Related Experiment Videos
Treatment of infections due to resistant organisms
1Paediatric Infectious Disease Unit, St George's Hospital, London, UK.
Insights
Antibiotic resistance in pediatric pneumonia is uncommon in the UK, but warrants consideration in specific high-risk groups. Emerging penicillin resistance in Streptococcus pneumoniae is a concern, though current vaccines may offer protection.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Resistance
- Respiratory Medicine
Background:
- Antibiotic resistance in pediatric pneumonia is a growing global health concern.
- While rare in community-acquired cases in the UK, resistance is more prevalent in hospital-acquired pneumonia and in children with chronic lung conditions.
Purpose of the Study:
- To assess the prevalence and implications of antibiotic resistance in pediatric pneumonia.
- To identify risk factors for antibiotic resistance in pediatric pneumonia cases.
- To evaluate the impact of Streptococcus pneumoniae resistance and the role of vaccination.
Main Methods:
- Review of existing literature and clinical data on pediatric pneumonia and antibiotic resistance.
- Analysis of resistance patterns for Streptococcus pneumoniae, a primary bacterial cause.
- Consideration of clinical outcomes in relation to antibiotic resistance levels.
Main Results:
- Antibiotic resistance is infrequent in UK pediatric community-acquired pneumonia but more common in hospital-acquired cases and in specific patient subgroups.
- Penicillin resistance in Streptococcus pneumoniae is increasing globally, but intermediate resistance may be manageable with standard treatments.
- No clear evidence links intermediate/high-level resistance to worse clinical outcomes currently.
Conclusions:
- Continued surveillance and research into antibiotic resistance in pediatric pneumonia are essential.
- Pneumococcal conjugate vaccines show promise in preventing diseases caused by penicillin-resistant strains.
- Risk factors for resistance include travel from high-prevalence areas, prior antibiotic exposure, immunosuppression, and treatment non-response.
Abstract:
Antibiotic resistance remains rare in paediatric community-acquired pneumonia in the UK, but is more common in hospital-acquired pneumonia and in patients with chronic lung diseases. It should also be considered in children arriving from countries with a high prevalence of antibiotic resistance, children with previous heavy antibiotic exposure, those who are immunosuppressed, and those who are not responding to conventional therapy. The most frequent bacterial cause of paediatric pneumonia is Streptococcus pneumoniae and globally there are major concerns about the increasing resistance of this organism to penicillin. Intermediate resistance may be overcome with conventional doses of parenteral penicillin and there is as yet no convincing evidence that intermediate/high level resistance is associated with a worse clinical outcome. Continued vigilance and research is required. The recently introduced pneumococcal conjugate vaccines offer great promise as they are likely to prevent cases of disease due to penicillin-resistant serotypes.